Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer

Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer

<p>Abstract</p> <p>Background</p> <p>The combination of gemcitabine (GEM) and S-1, an oral 5-fluorouracil (5-FU) derivative, has been shown to be a promising regimen for patients with unresectable pancreatic cancer.</p> <p>Methods</p> <p>Six pati...

Full description

Bibliographic Details
Main Authors: Okita Yoshihiro, Hirakawa Toshiki, Shinto Osamu, Tamura Tatsuro, Nakao Shigetomi, Amano Ryosuke, Nakata Bunzo, Yamada Nobuya, Hirakawa Kosei
Format: Article
Language:English
Published: BMC 2010-02-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/29/1/15

Internet

http://www.jeccr.com/content/29/1/15

Similar Items